Vertex Pharmaceuticals | Caixa E Equivalentes



Cash And Equivalent Alterar Data
AbbVie USD 5.18B 349M 2025-03
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Alnylam Pharmaceuticals USD 1.11B 94.03M 2025-06
Amgen USD 8.81B 3.16B 2025-03
Arrowhead Research USD 185.71M 133.92M 2025-03
Biogen USD 2.76B 160.5M 2025-06
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Gilead Sciences USD 7.93B 2.06B 2025-03
Incyte USD 2.42B 13.08M 2025-06
Insmed USD 403.25M 151.78M 2025-03
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
J&J USD 38.47B 32.35B 2025-03
Merck USD 8.63B 4.61B 2025-03
Moderna USD 1.62B 304M 2025-03
Neurocrine Biosciences USD 264M 69.9M 2025-06
Novartis USD 6.66B 410M 2025-06
Pfizer USD 1.43B 387M 2025-03
PTC Therapeutics USD 2.03B 1.25B 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 7.99B 550M 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
United Therapeutics USD 1.59B 306.8M 2025-06
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12


Vertex Pharmaceuticals Caixa E Equivalentes - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.